SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-252840
Filing Date
2017-08-09
Accepted
2017-08-09 16:28:52
Documents
51
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d408533d10q.htm 10-Q 646299
2 EX-31.1 d408533dex311.htm EX-31.1 6425
3 EX-31.2 d408533dex312.htm EX-31.2 6225
4 EX-32.1 d408533dex321.htm EX-32.1 5632
  Complete submission text file 0001193125-17-252840.txt   2565645

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT zfgn-20170630.xml EX-101.INS 401482
6 XBRL TAXONOMY EXTENSION SCHEMA zfgn-20170630.xsd EX-101.SCH 30433
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE zfgn-20170630_cal.xml EX-101.CAL 46782
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zfgn-20170630_def.xml EX-101.DEF 76819
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE zfgn-20170630_lab.xml EX-101.LAB 234940
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zfgn-20170630_pre.xml EX-101.PRE 158678
Mailing Address 175 PORTLAND STREET 4TH FLOOR BOSTON MA 02114
Business Address 175 PORTLAND STREET 4TH FLOOR BOSTON MA 02114 617-622-4003
ZAFGEN, INC. (Filer) CIK: 0001374690 (see all company filings)

IRS No.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36510 | Film No.: 171018308
SIC: 2834 Pharmaceutical Preparations